Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc.

World Rank (Jan-05-2024)
16,628
Market Cap (Jan-05-2024)
0.256 Billion USD
World Rank (Jul-30-2023)
14,496
Market Cap (Jul-30-2023)
0.378 Billion USD
World Rank (Jan-07-2022)
11,175
Market Cap (Jan-07-2022)
0.742 Billion USD
World Rank (Jan-01-2021)
9,242
Market Cap (Jan-01-2021)
0.745 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
FHTX
Market Cap (Mar-08-2026)
0.33
Employee Count
85
Employee Count as of Date
As on August 2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1 Million USD
Annual Net Income in USD
-101 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
519 Million USD
Total Liabilities in USD
422 Million USD
Total Equity in USD
96 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
FOGHORN THERAPEUTICS INC.
Company Profile
Foghorn Therapeutics Inc. is Developing Therapies designed to modulate the chromatin regulatory system company. The company estimated annual revenue is currently 17.8 million USD per year and 85 employees as on 2020. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share